Soleiman applies decades of clinical decision-making to laboratory interpretation, side-effect management, and riskbenefit counseling for GLP1based therapies
When this refinery is stressed or clogged with fat, it loses the ability to maintain quality control, releasing high-risk particles that trigger a cascade of inflammation and metabolic instability
What to monitor: Everything listed above, plus liver function markers if accessible, heart rate (glucagon can modestly increase heart rate), and overall quality of life
If your appetite is suppressed, you need to be more intentional, not less
That isnt to say you cant (or shouldnt) stop taking these medications if your side effects are severe
The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies